Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Endocrine 2Thoracic 1Breast 1

Conditions

Lung Neoplasms 58Carcinoma, Non-Small-Cell Lung 53Breast Neoplasms 19Pancreatic Neoplasms 11Small Cell Lung Carcinoma 9Ovarian Neoplasms 9Melanoma 9Colorectal Neoplasms 8Colonic Neoplasms 8Stomach Neoplasms 7Sarcoma 7Head and Neck Neoplasms 7Neoplasms 6Pleural Effusion, Malignant 5Mesothelioma 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Osteosarcoma 3Neoplasm Metastasis 3Glioblastoma 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Rectal Neoplasms 2Pulmonary Disease, Chronic Obstructive 2NSCLC 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Adrenal Gland Neoplasms × Thoracic × Clear all
NCT01086696 2019-12-17

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
6 enrolled
BreastEndocrineGenitourinaryThoracic

Adrenal Gland Neoplasms, Breast Neoplasms, Kidney Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡